Skip to main content

Monitoring > The Sensor Project

 

We wish to get these sensors and apps to women and children everywhere. Each $100 donated to The Sensor Project will purchase the development, deployment and user training of one sensor. 

What is the Sensor Project?

We have pioneered the use of oxygen saturation as a tool for identifying women and children at risk of life threatening complications of diseases such as pre-eclampsia and pneumonia.

Early identification of health risks by combining the oxygen saturation sensor and other sensors and integrating this information into smart mobile applications will help save lives. It will enable community healthcare workers to recommend interventions and individuals at home to seek healthcare, before complications arise.

We wish to get these sensors and apps to women and children everywhere. Each $100 donated to The Sensor Project will purchase the development, deployment and user training of one sensor.  Many hospitals around the world do not have any sensors – even for use during anesthesia. We wish to make our sensors available in hospitals and clinics – especially in resource poor and remote areas where these devices have not been available.

Current Status

The inaugural goal of The Sensor Project was to raise $37,500 to supply sensors and training to rural health workers as part of the CLIP Trial. Thanks to our donors' commitments to the Sensor Project, we have achieved this remarkable milestone. In addition, we were able to provide an additional 266 sensors to sites in Mozambique and Pakistan, due to the CLIP team assisting with training of the CHWs.

The opportunities provided by our funders have empowered rural health workers in our CLIP study sites in Africa and Asia to use oxygen saturation as a tool to diagnose high-risk pregnancies and refer pregnant women to higher care, thus averting deaths and illness for mothers and babies.

As of February 2016, 641 sensors were provided to CHWs:

1,978 antenatal visits in Mozambique and 6,248 antenatal visits in Pakistan have been undertaken using the sensor, resulting in combined 18 referrals from measuring oxygen saturation alone, to the higher care facilities, potentially averting death and other adverse outcomes of pre-eclampsia.

But we have much more work to do:

  • Many hospitals around the world do not have access to oximeters – even for use during anesthesia.
  • We wish to make our sensors available in hospitals and clinics – especially in resource poor and remote areas where these devices have not been available.
  • Oximetry, alongside smart mobile health applications, can quickly detect the deterioration of patients from other conditions that are significant causes of death, such as pneumonia and sepsis, in both pediatric and adult patients.

We are continuing to develop new vital signs sensor technologies and mobile health applications, to address the challenges of providing equitable health care in low resource settings.

For more information on the Sensor Project or to donate, please visit http://www.thesensorproject.org